Data Collection

All providers participating in the project engage in data collection activities. Data is collected on women diagnosed with GDM at two different points in her care plan. Prenatal measures are collected between 33-36 weeks gestation and postpartum measures are collected by 12 weeks after delivery.

Prenatal Measures Postpartum Measures

1.

% of women had a GDM screen during the recommended timeframe

2.

% of women diagnosed with GDM who had evidence of prenatal education on benefits and/or risks in all of the following areas:

  • Postpartum family planning
  • Breastfeeding
  • Risk of developing Type 2 Diabetes for both mom and baby
  • Importance of receipt of OGTT screen between

1.

% of women diagnosed with GDM during the prenatal period who attended at least one postpartum care visit after delivery

2.

% of women who received one or more care coordination strategies to improve the rate of postpartum T2DM screen by 56 days **

  • OGTT screen ordered while in hospital postpartum
  • Postpartum T2DM reminder sent via postcard, follow up phone call, e-mail and/or text message within 56 days of delivery
  • Outreach to PCP via fax letter, phone call or other to inform of need for Postpartum T2DM screen and request verification that screen was conducted
  • Other strategies

3.

% of women with GDM during the prenatal period who had an oral glucose tolerance test (OGTT) prior to 12 weeks

A full list of measures collected and definitions can be found here. Data is submitted and analyzed on a monthly basis and provided to participating sites for review. This data-feedback loop ensure teams can quickly address areas for improvement. For more information on QIC, please visit www.ihi.org.